Skip to main content
. Author manuscript; available in PMC: 2009 Nov 30.
Published in final edited form as: Nat Immunol. 2008 Jun 22;9(8):873–879. doi: 10.1038/ni.1627

Figure 2.

Figure 2

RvE1 promotes resolution of airway inflammation. a, Schematic diagram showing the protocol used to determine the impact of RvE1 (100ng, i.v., days 18-20) or vehicle on the resolution of airway inflammation. b,c On day 21, total BALF cells b and leukocyte subsets c were counted. d, Using the mean number of BALF leukocytes on day 18, 21 and 25, the resolution interval (Ri) was calculated for RvE1 and vehicle cohorts. Values represent the mean ± s.e.m. for n ≥ 8 in ≥ 4 independent experiments, *, P <0.05 by Student's t-test.